title: Global Vaccine and Immunization Research Forum: Opportunities and challenges in vaccine discovery, development, and delivery.
abstract: The World Health Organization, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and the Bill & Melinda Gates Foundation convened the first Global Vaccine and Immunization Research Forum (GVIRF) in March 2014. This first GVIRF aimed to track recent progress of the Global Vaccine Action Plan research and development agenda, identify opportunities and challenges, promote partnerships in vaccine research, and facilitate the inclusion of all stakeholders in vaccine research and development. Leading scientists, vaccine developers, and public health officials from around the world discussed scientific and technical challenges in vaccine development, research to improve the impact of immunization, and regulatory issues. This report summarizes the discussions and conclusions from the forum participants.
authors.affiliation: Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States. Electronic address: andrew.ford@nih.gov.
authors.forename: Andrew Q
authors.initials: AQ
authors.lastname: Ford
authors.affiliation: Office of Global Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
authors.forename: Nancy
authors.initials: N
authors.lastname: Touchette
authors.affiliation: Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
authors.forename: B Fenton
authors.initials: BF
authors.lastname: Hall
authors.affiliation: Bill & Melinda Gates Foundation, Seattle, WA, United States.
authors.forename: Angela
authors.initials: A
authors.lastname: Hwang
authors.affiliation: Department of Immunization, Vaccines, and Biologicals, World Health Organization (WHO), Geneva, Switzerland.
authors.forename: Joachim
authors.initials: J
authors.lastname: Hombach
mesh_terms: D016915:AIDS Vaccines; D035843:Biomedical Research / Q000639:trends*; D003226:Congresses as Topic; D005582:Foundations; D014943:Global Health; D006291:Health Policy; D006801:Humans; D007114:Immunization; D007252:Influenza Vaccines; D017780:Malaria Vaccines; D054579:National Institute of Allergy and Infectious Diseases (U.S.); D032581:Tuberculosis Vaccines; D014481:United States; D014612:Vaccines; D014944:World Health Organization
chemical_list: D016915:AIDS Vaccines; D007252:Influenza Vaccines; D017780:Malaria Vaccines; D032581:Tuberculosis Vaccines; D014612:Vaccines
keywords: GVAP; GVIRF